natgillin/translations-raw huggingface dataset:
Levetiracetam efficacy was established in a 24-week double-blind, placebo-controlled study, which included adults, adolescents and a limited number of children suffering from idiopathic generalized epilepsy with primary generalized tonic-clonic (PGTC) seizures in different syndromes (juvenile myoclonic epilepsy, juvenile absence epilepsy, childhood absence epilepsy, or epilepsy with Grand Mal seizures on awakening).
Djelotvornost levetiracetama dokazana je u dvostruko-slijepoj i s placebom kontroliranoj studiji u trajanju od 24 tjedna, koja je uključivala odrasle, adolescente i ograničeni broj djece s idiopatskom generaliziranom epilepsijom s primarno generaliziranim toničko-kloničkim (PGTK) napadajima kod različitih sindroma (juvenilna mioklonična epilepsija, epilepsija s apsansima dječje i juvenilne dobi ili epilepsija s grand mal napadajima kod buđenja).
Levetiracetam has been given to you by your doctor to reduce the number of fits
Vaš liječnik Vam je propisao levetiracetam kako bi se smanjio broj napadaja.
Levetiracetam has minor or moderate influence on the ability to drive and use machines.
Levetiracetam malo ili umjereno utječe na sposobnost upravljanja vozilima i rada sa strojevima .
Levetiracetam has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures.
U ispitivanjima na životinjskim modelima utvrđeno je da je levetiracetam povezan s neželjenim reproduktivnim učincima kada je primjenjivan u dozama većim nego što bi bile potrebne za kontrolu Vaših napadaja.
Levetiracetam has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures.
U ispitivanjima na životinjskim modelima, utvrđeno je da je Levetiracetam Hospira povezan s neželjenim reproduktivnim učincima kada je primjenjivan u dozama većim nego što bi bile potrebne za kontrolu Vaših napadaja.
Levetiracetam Hospira 100 mg/ml concentrate for solution for infusion Levetiracetam
Levetiracetam Hospira 100 mg/ml koncentrat za otopinu za infuziju levetiracetam
Levetiracetam Hospira 100 mg/ml sterile concentrate Levetiracetam
Levetiracetam Hospira 100 mg/ml sterilni koncentrat levetiracetam i.v.
Levetiracetam Hospira concentrate for solution for infusion (sterile concentrate) is a clear, colourless solution.
Levetiracetam Hospira koncentrat za otopinu za infuziju (sterilni koncentrat) je bistra, bezbojna, otopina.
Levetiracetam Hospira concentrate for solution for infusion is an alternative for patients when administration of the antiepileptic levetiracetam medicine by mouth is temporarily not feasible.
Levetiracetam Hospira koncentrat za otopinu za infuziju se koristi kao alternativni lijek kod bolesnika kod kojih privremeno nije moguće primjeniti antiepileptik levetiracetam kroz usta.
Levetiracetam Hospira concentrate for solution for infusion is packed in a cardboard box containing 10 or 25 vials of 5 ml.
Levetiracetam Hospira koncentrat za otopinu za infuziju pakirana je u kutije od 10 ili 25 bočica od 5 ml.
Levetiracetam Hospira concentrate is for intravenous use only and the recommended dose must be diluted in at least 100 ml of a compatible diluent and administered intravenously as a 15-minute intravenous infusion (see section 6.6).
Levetiracetam Hospira koncentrat je isključivo za intravensku primjenu i preporučena doza mora se razrijediti u najmanje 100 ml kompatibilnog otapala i primijeniti intravenski kao 15 minutna intravenska infuzija (vidjeti dio 6.6).
Levetiracetam Hospira concentrate was found to be physically compatible and chemically stable when mixed with the following diluents:
Utvrđeno je da je Levetiracetam koncentrat fizički kompatibilan i kemijski stabilan ako se miješa sa sljedećim otapalima:
Levetiracetam Hospira is for intravenous use.
Levetiracetam Hospira je namijenjen za intravensku primjenu.
Levetiracetam Hospira is not indicated in children and adolescents below 16 years on it’s own (monotherapy)
Levetiracetam Hospira nije indiciran za samostalnu primjenu (monoterapija) u liječenju djece i adolescenata mlađih od 16 godina
Levetiracetam Hospira is used:
Levetiracetam Hospira se koristi:
Levetiracetam Hospira must be administered twice a day, once in the morning and once in the evening, at about the same time each day.
Levetiracetam Hospira se mora uzimati dva puta na dan, jednom ujutro i jednom navečer, u približno isto vrijeme svaki dan.
Levetiracetam Hospira should not be used during pregnancy unless clearly necessary.
Levetiracetam Hospira se ne smije uzimati tijekom trudnoće, osim ako je to neophodno.
Levetiracetam is an antiepileptic medicine (a medicine used to treat seizures in epilepsy).
Levetiracetam jest antiepileptik (lijek koji se koristi u liječenju epileptič kih napadaja).
Levetiracetam is not recommended during pregnancy and in women of childbearing potential not using contraception unless clinically necessary.
Ne preporučuje se koristiti evetiracetam tijekom trudnoće niti u žena reproduktivne dobi koje ne koriste kontracepciju, osim ako to nije klinički neophodno.
Levetiracetam is not recommended during pregnancy and in women of childbearing potential not using contraception unless clinically necessary.
Ne preporučuje se koristiti levetiracetam tijekom trudnoće niti u žena reproduktivne dobi koje ne koriste kontracepciju, osim ako je to klinički neophodno.
Levetiracetam is not recommended during pregnancy and in women of childbearing potential not using contraception unless clinically necessary.
Ne preporučuje se primjena levetiracetama tijekom trudnoće i u žena u generativnoj dobi koje ne uzimaju kontracepciju, osim ako to nije klinički neophodno.
Levetiracetam is not recommended during pregnancy and in women of childbearing potential not using contraception unless clinically necessary.
Ne preporučuje se primjena levetiracetama tijekom trudnoće i u žena u reproduktivnoj dobi koje ne uzimaju kontracepciju, osim ako to nije klinički neophodno.
Levetiracetam is used for the epilepsy form in which the fits initially affect only one side of the brain, but could thereafter extend to larger areas on both sides of the brain (partial onset seizure with or without secondary generalisation).
Levetiracetam se koristi za oblik epilepsije u kojem napadaji započinju u jednoj strani mozga, ali se nakon toga mogu proširiti na veće područje u obje strane mozga (parcijalni napadaj sa sekundarnom generalizacijom ili bez nje).
Levetiracetam ratiopharm 100 mg/ml oral solution contains methyl parahydroxybenzoate (E 218) and propyl parahydroxybenzoate (E 216) which may cause allergic reactions (possibly delayed).
Levetiracetam ratiopharm 100 mg/ml oralna otopina sadrži metilparahidroksibenzoat (E218) i propilparahidroksibenzoat (E216) koji mogu izazvati alergijske reakcije (koje mogu biti i odgođene).
Levetiracetam ratiopharm 100 mg/ml oral solution For children aged 1 month to less than 6 months.
Levetiracetam ratiopharm 100 mg/ml oralna otopina Za djecu u dobi od 1 mjesec do manje od 6 mjeseci.
Levetiracetam ratiopharm 100 mg/ml oral solution For children between 1 and 6 months.
Levetiracetam ratiopharm 100 mg/ml oralna otopina Za djecu u dobi od 1 do 6 mjeseci.
Levetiracetam ratiopharm 100 mg/ml oral solution is a formulation more appropriate to infants and children under the age of 6 years and to children and adolescent (from 6 to 17 years) weighing less than 50 kg and when tablets don’t allow accurate dosage.
Levetiracetam ratiopharm 100 mg/ml oralna otopina je prikladniji farmaceutski oblik za primjenu u dojenčadi i djece mlađe od 6 godina, djece i adolescenata (6-17 godina) tjelesne težine manje od 50 kg te kada se tabletama ne može postići točno doziranje.
Levetiracetam ratiopharm 100 mg/ml oral solution is the preferred formulation for use in infants and children under the age of 6 years.
Levetiracetam ratiopharm 100 mg/ml oralna otopina najprikladniji je farmaceutski oblik za primjenu kod dojenčadi i djece mlađe od 6 godina.
Levetiracetam ratiopharm 100 mg/ml oral solution is the preferred formulation for use in this population.
Najprikladniji farmaceutski oblik za primjenu u toj populaciji je Levetiracetam ratiopharm 100 mg/ml oralna otopina.
Levetiracetam ratiopharm 500 mg film-coated tablets EU/1/11/702/010
Levetiracetam ratiopharm 500 mg filmom obložene tablete EU/1/11/702/010
Levetiracetam ratiopharm has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures.
U ispitivanjima na životinjskim modelima, utvrđeno je da je Levetiracetam ratiopharm povezan s neželjenim reproduktivnim učincima kada je primjenjivan u dozama većim nego što bi bile potrebne za kontrolu Vaših napadaja.
Levetiracetam ratiopharm has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures.
U ispitivanjima na životinjskim modelima, utvrđeno je da je Levetiracetam ratiopharm povezana s neželjenim reproduktivnim učincima kada je primjenjivana u dozama većim nego što bi bile potrebne za kontrolu Vaših napadaja.
Levetiracetam ratiopharm is not indicated in children and adolescents below 16 years on its own (monotherapy).
U djece i adolescenata mlađih od 16 godina Levetiracetam ratiopharm se ne primjenjuje samostalno (monoterapija).
Levetiracetam ratiopharm is not indicated in children and adolescents below 16 years on it’s own (monotherapy)
U djece i adolescenata mlađih od 16 godina Levetiracetam ratiopharm se ne primjenjuje samostalno (monoterapija).
Levetiracetam ratiopharm is used as a chronic treatment.
Levetiracetam ratiopharm se koristi za dugotrajno liječenje.
Levetiracetam ratiopharm oral solution may be diluted in a glass of water or baby’s bottle.
Levetiracetam ratiopharm oralna otopina može se razrijediti u čaši vode ili u dječjoj bočici.
Levetiracetam ratiopharm should not be used during pregnancy unless clearly necessary.
Levetiracetam ratiopharm se ne smije uzimati tijekom trudnoće, osim ako je to neophodno.
Levetiracetam SUN 100 mg/ml concentrate for solution for infusion
Levetiracetam SUN 100 mg/ml koncentrat za otopinu za infuziju
Levetiracetam SUN 100 mg/ml concentrate for solution for infusion Levetiracetam
Levetiracetam SUN 100 mg/ml koncentrat za otopinu za infuziju levetiracetam
Levetiracetam SUN concentrate for solution for infusion (sterile concentrate) is a clear, colourless liquid.
Levetiracetam SUN koncentrat za otopinu za infuziju (sterilni koncentrat) je bistra, bezbojna tekućina.
Levetiracetam SUN concentrate is for intravenous use only and the recommended dose must be diluted in at least 100 ml of a compatible diluent and administered intravenously as a 15-minute intravenous infusion (see section 6.6).
Levetiracetam SUN koncentrat je samo za intravensku primjenu i preporučena doza se mora razrijediti u najmanje 100 ml kompatibilne otopine za razrjeđivanje i primjeniti intravenski kao 15- minutna intravenska infuzija (vidjeti dio 6.6).
Levetiracetam SUN has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures.
U ispitivanjima na životinjskim modelima, utvrđeno je da je Levetiracetam SUN povezana s neželjenim reproduktivnim učincima kada je primjenjivana u dozama većim nego što bi bile potrebne za kontrolu Vaših napadaja.
Levetiracetam SUN is indicated as adjunctive therapy
Levetiracetam SUN je indiciran kao dodatna terapija
Levetiracetam SUN is not indicated in children and adolescents below 16 years on its own (monotherapy).
U djece i adolescenata mlađih od 16 godina Levetiracetam SUN se ne primjenjuje samostalno (monoterapija).
Levetiracetam SUN is used
Levetiracetam SUN se koristi
Levetiracetam SUN should not be used during pregnancy unless clearly necessary.
Levetiracetam SUN se ne smije uzimati tijekom trudnoće, osim ako je to neophodno.
Levetiracetam Teva 1000 mg film-coated tablets
Levetiracetam Teva 1000 mg filmom obložene tablete
Levetiracetam Teva 250 mg film-coated tablets Levetiracetam Teva 500 mg film-coated tablets Levetiracetam Teva 750 mg film-coated tablets Levetiracetam Teva 1,000 mg film-coated tablets
Levetiracetam Teva 250 mg filmom obložene tablete Levetiracetam Teva 500 mg filmom obložene tablete Levetiracetam Teva 750 mg filmom obložene tablete Levetiracetam Teva 1000 mg filmom obložene tablete
Levetiracetam Teva are available in pack sizes of 20, 30, 50, 60, 100, 120 and 200 film-coated tablets and 50 x 1 film-coated tablets in PVC/PVdC – aluminium perforated unit dose blisters.
Levetiracetam Teva je dostupan u pakiranju od 20, 30, 50, 60, 100, 120 i 200 filmom obloženih tableta i 50 x 1 filmom obloženih tableta u PVC/PVdC-aluminij perforiranim blisterima djeljivim na jedinične doze.
Levetiracetam Teva has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures.
U ispitivanjima na životinjskim modelima utvrđeno je da je Levetiracetam Teva povezan s neželjenim reproduktivnim učincima kada je primjenjivan u dozama većim nego što bi bile potrebne za kontrolu Vaših napadaja.
Levetiracetam Teva is a ‘generic medicine’.
Levetiracetam je „generički lijek”.
Levetiracetam Teva is not indicated in children and adolescents below 16 years on its own (monotherapy).
Levetiracetam Teva nije indiciran u djece i adolescenata mlađih od 16 godina kao samostalni lijek (monoterapija).
Levetiracetam Teva is used as a chronic treatment.
Levetiracetam Teva se koristi za dugotrajno liječenje.
Levetiracetam Teva should not be used during pregnancy unless clearly necessary.
Levetiracetam Teva se ne smije uzimati tijekom trudnoće, osim ako je to neophodno.
Levitra 10 mg film-coated tablets
Levitra 10 mg filmom obložene tablete
Levitra 10 mg film-coated tablets are orange with the BAYER cross on one side and the strength (10) on the other side.
Levitra 10 mg filmom obložene tablete narančaste su s ukriženim riječima BAYER s jednoe strane i jačinom (10) s drugoe strane.
Levitra 10 mg orodispersible tablet is not bioequivalent to Levitra 10 mg film-coated tablet (see section 5.1).
Levitra 10 mg raspadljiva tableta za usta nije bioekvivalentna Levitra 10 mg filmom obloženoj tableti (vidjeti dio 5.1).
Levitra 10 mg orodispersible tablets
Levitra 10 mg raspadljive tablete za usta
Levitra 10 mg orodispersible tablets contain aspartame, a source of phenylalanine which may be harmful for people with phenylketonuria.
Levitra 10 mg raspadljive tablete za usta sadrže aspartam, izvor fenilalanina koji može štetiti osobama s fenilketonurijom.
Levitra 10 mg orodispersible tablets contain sorbitol.
Levitra 10 mg raspadljive tablete za usta sadrže sorbitol.
Levitra 10 mg orodispersible tablets contains Aspartame and Sorbitol.
Levitra 10 mg raspadljive tablete za usta sadrže aspartam i sorbitol.
Levitra 10 mg orodispersible tablets should not be taken as starting dose in patients treated with alpha-blockers (see section 4.4).
Bolesnici koji se liječe alfa blokatorima ne smiju uzimati Levitra 10 mg raspadljive tablete za usta kao početnu dozu.
Levitra 20 mg film-coated tablets
Levitra 20 mg filmom obložene tablete
Levitra 20 mg film-coated tablets are orange with the BAYER cross on one side and the strength (20) on the other side.
Levitra 20 mg filmom obložene tablete narančaste su s ukriženim riječima BAYER s jednoe strane i jačinom (20) s druge strane.
Levitra 5 mg film-coated tablets
Levitra 5 mg filmom obložene tablete
Levitra contains vardenafil, a member of a class of medicines called phosphodiesterase type 5 inhibitors.
Levitra sadrži vardenafil, koji pripada skupini lijekova koji se zovu inhibitori fosfodiesteraze tipa 5.
Levitra is not for use by women.
Levitra nije namijenjena primjeni u žena.
Levitra is not intended for use by children or adolescents under 18.
Levitra nije namijenjena za primjenu u djece i adolescenata mlađih od 18 godina.
Levitra must not be taken with ketoconazole and itraconazole (used to treat fungal infections) in men over 75 years of age, or with medicines called ‘HIV protease inhibitors’ such as ritonavir or indinavir (used to treat HIV infection).
Levitra se ne smije primjenjivati s nekim lijekovima poput ketokonazola i itrakonazola (za liječenje gljivičnih infekcija) u muškaraca starijih od 75 godina ili s lijekovima zvanima „inhibitori proteaze HIV- a” poput ritonavira ili indinavira (za liječenje infekcije HIV-om).
Levitra with food, drink and alcohol
Levitra s hranom, pićem i alkoholom
Levodopa competes with certain amino acids for transport, therefore high protein meals may impair the absorption of levodopa.
Levodopa se s nekim aminokiselinama natječe za prijenos, stoga visokoproteinski obroci mogu smanjiti apsorpciju levodope.
Levodopa crosses the blood-brain barrier by active transporters for large neutral amino acids.
Levodopa prolazi krvno- moždanu barijeru aktivnim prijenosnicima za velike neutralne aminokiseline.
Levodopa increases the amount of dopamine and hence reduces the symptoms of Parkinson’s disease.
Levodopa povećava količinu dopamina i na taj način smanjuje simptome Parkinsonove bolesti.
Levodopa is bound to plasma protein only to a minor extent of about 10-30% and carbidopa is bound approximately 36%, while entacapone is extensively bound to plasma proteins (about 98%) –mainly to serum albumin.
Levodopa se veže na bjelančevine plazme samo malim udjelom od oko 10-30%, karbidopa se veže otprilike 36%, dok se entakapon ekstenzivno veže na bjelančevine plazme (oko 98%), uglavnom na serumski albumin.
levodopa is extensively metabolised in the periphery, only a small portion of a given dose reaches the central nervous system when levodopa is administered without metabolic enzyme inhibitors.
Kako se levodopa ekstenzivno metabolizira u periferiji, samo mali dio primijenjene doze dospijeva u središnji živčani sustav kada se levodopa primijeni bez inhibitora metaboličkih enzima.
Levodopa-naïve patients with Parkinson’s disease APEX-PD
Bolesnici s Parkinsonovom bolešću koji nisu liječeni levodopom APEX-PD
Levodopa/carbidopa may cause false positive result when a dipstick is used to test for urinary ketone and this reaction is not altered by boiling the urine sample.
Levodopa/karbidopa mogu dati lažno pozitivan rezultat za određivanje ketonskih tijela u mokraći test-trakicom, a ta se reakcija ne mijenja vrenjem uzorka mokraće.
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg filmom obložene tablete
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg: brownish or greyish red, oval, unscored film-coated tablets marked with ‘LCE 100’ on one side.
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg: smećkasto ili sivkasto-crvene, ovalne filmom obložene tablete, bez ureza, s oznakom "LCE 100" na jednoj strani.
Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 125 mg/31,25 mg/200 mg filmom obložene tablete
Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 125 mg/31,25 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Levodopa/Carbidopa/Entacapone Orion 125 mg/31,25 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg tablet comes in five different pack sizes (10, 30, 100, 130 or 175 tablets).
Levodopa/Carbidopa/Entacapone Orion 125 mg/31,25 mg/200 mg tablete dolazi u pet različitih veličina pakiranja (10, 30, 100, 130, ili 175 tableta).
Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg: light brownish red, oval film- coated tablets marked with ‘LCE 125’ on one side.
Levodopa/Carbidopa/Entacapone Orion 125 mg/31,25 mg/200 mg: svijetlo smećkasto-crvene, ovalne filmom obložene tablete, s oznakom "LCE 125" na jednoj strani.
Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg filmom obložene tablete
Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Levodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg: brownish or greyish red, elongated- ellipse shaped, unscored film-coated tablets marked with ‘LCE 150’ on one side.
Levodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg: smećkasto- ili sivkasto-crvene, izdužene filmom obložene tablete u obliku elipse, bez ureza, s oznakom "LCE 150" na jednoj strani.
Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 175 mg/43,75 mg/200 mg filmom obložene tablete
Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 175 mg/43,75 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Levodopa/Carbidopa/Entacapone Orion 175 mg/43,75 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg tablet comes in five different pack sizes (10, 30, 100, 130 or 175 tablets).
Levodopa/Carbidopa/Entacapone Orion 175 mg/43,75 mg/200 mg tablete dolazi u pet različitih veličina pakiranja (10, 30, 100, 130, ili 175 tableta).
Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg: light brownish red, oval, unscored film-coated tablets marked with ‘LCE 175’ on one side.
Levodopa/Carbidopa/Entacapone Orion 175 mg/43,75 mg/200 mg: svijetlo smećkasto-crvene, ovalne filmom obložene tablete, bez razdjelnog ureza, s oznakom ‘LCE 175’ na jednoj strani.
levodopa/carbidopa/entacapone orion 175/43.75/200 mg
levodopa/carbidopa/entacapone orion 175/43,75/200 mg
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg filmom obložene tablete
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg tablet comes in five different pack sizes (10, 30, 100, 130 or 175 tablets).
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg tablete dolazi u pet različitih veličina pakiranja (10, 30, 100, 130, ili 175 tableta).
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg: dark brownish red, oval, unscored film-coated tablets marked with ‘LCE 200’ on one side.
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg: tamno smećkasto-crvene, ovalne filmom obložene tablete, bez ureza, s oznakom "LCE 200" na jednoj strani.
Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 50 mg/12,5 mg/200 mg filmom obložene tablete
Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Orion 50 mg/12,5 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon
Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Levodopa/Carbidopa/Entacapone Orion 50 mg/12,5 mg/200 mg filmom obložene tablete levodopa/karbidopa/entakapon